Agnes
Agnes® (Icatibant) is a selective bradykinin B2 receptor antagonist indicated for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents, and children 2 years of age and older.
Therapeutic Area
Rare Diseases
Active Ingredient
Icatibant
Line
Rare Diseases
Presentation:
30 mg/3 mL Solution for Injection in a Pre-filled Syringe
